Advertisement
Home »

Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis.

Jan 02, 2023

ABOUT THE CONTRIBUTORS

  • Donald Y M Leung

    National Jewish Health, Denver, CO, USA. Electronic address: leungD@njhealth.org.

    Amy S Paller

    Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

    Andrea L Zaenglein

    Penn State Health Hershey Medical Center, Hershey, PA, USA.

    Wynnis L Tom

    University of California, San Diego and Rady Children’s Hospital, San Diego, CA, USA.

    Peck Y Ong

    Children’s Hospital Los Angeles, Los Angeles, CA, USA.

    May E Venturanza

    Incyte Corporation, Wilmington, DE, USA.

    Michael E Kuligowski

    Incyte Corporation, Wilmington, DE, USA.

    Qian Li

    Incyte Corporation, Wilmington, DE, USA.

    Xiaohua Gong

    Incyte Corporation, Wilmington, DE, USA.

    Mark S Lee

    Progressive Clinical Research, San Antonio, TX, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement